INTRODUCTION
There is increasing evidence that the enthesis organ and biomechanically related structures may be an important site for disease initiation in spondyloarthropathy (SpA) (1, 2) . In animal models, including IL-23 and TNFα overexpression systems, primary entheseal disease results in subsequent spreading to the adjacent synovium and bone (1, 3) . Until recently, the enthesis with its avascular region of fibrocartilage at the bone interface and adjacent tendon, ligament or capsules that are composed of fibrocartilage and dense stromal connective tissue was not studied as an immune organ. However, the seminal work of Sherlock and colleagues showed that the normal murine enthesis had a low abundance of immune cells that were IL-23 dependent that are nevertheless, critical to SpA pathogenesis (1) .
The description of a family of cytokine dependent innate lymphoid cells (ILCs) , that play a pivotal role in barrier tissue homeostasis, repair and inflammation (4, 5) has led to major new avenues for inflammatory disease immunopathogenesis investigation. In recent years, the importance of ILCs in gut and skin, both targets of SpA in man, has been reported with a possible role for these cells in tissue repair and homeostasis (4, 5) . Since the normal mechanically stressed human enthesis is a site of microdamage and miscroscopic inflammation in normal aged enthesis, it is feasible that the human enthesis under physiological conditions may also contain ILCs.
In humans, ILCs can be broadly subdivided into three main categories; ILC1s which are defined by their ability to produce IFNγ, ILC2s that are able to produce T H 2 associated cytokines and an ILC3 subpopulation characterised by expression of the truncated retinoic acid-receptor (RAR)-related orphan receptor gamma (RORγt) (5) . Human SpAs are genetically linked to the IL-23/17 cytokine axis (6) and therapeutic antagonism of this pathway is effective in SpA (6) the ability of ILC3s to respond to IL-β / IL-23 signalling with IL-17 and IL-22 production is especially relevant (5) . Additionally, ILC3s are comparatively abundant in SpA related synovial fluid (7, 8) and have also been shown to be increased in psoriatic skin (9) and play a pivotal role in gut homeostasis and in experimental inflammatory bowel disease (4, 5, 7) . Given the importance of ILC3 in the skin and gut in addition to emerging animal model data, we hypothesised that the normal human enthesis harbours ILC3s with the potential for activation by local or systemic IL-23. Herein, we describe methodology for the assessment of human entheseal immune populations in health and following immune stimulation and provide a preliminary characterisation of human group 3 ILCs.
METHODS

Enthesis samples.
Normal inter-spinous process enthesis (n=13, median age 52, 8 male) were obtained from patients undergoing spinal decompression, or scoliosis correction surgery of thoracic or lumbar vertebrae. Unmatched peripheral blood was also collected both from patients undergoing surgery and from healthy controls (n=14, median age 42, 9 male). To compare normal entheseal ILC3s with those from active inflammatory disease, synovial fluid samples from knee synovitis in SpA were also examined (n=4).
To determine whether ILCs might be present at sites of enthesis damage, injured enthesis was obtained from patients undergoing surgical repair of ruptured Achilles' tendons with tissue being procured from the peri-entheseal rupture site (n=3). Similarly, anterior cruciate ligament (ACL), which is known to be damaged by the osteoarthiric process, was obtained from patients undergoing knee arthroplasty for the treatment of advanced osteoarthritis (n=7).
Digested Enthesis Immune cell cytometric evaluation.
Since the earliest lesions in human SpA appear to occur in either the enthesis soft tissue or in subfibrocartilagenous bone (10), both Entheseal soft tissue (EST) and peri-entheseal bone (PEB) was initially separated, see Figure 1A and digested in collagenase solution as previously described (11) RNA was isolated using PicoPure RNA isolation kit (ThermoFisher), and cDNA was synthesised using a high capacity reverse transcription kit (ThermoFisher). Pre-amplification of target transcripts was performed using GE PreAmp kit (Fluidigm, San Francisco, USA), this step was omitted in cytokine stimulation assays. Quantitative real-time PCR was performed using an ABI7500 (Applied Biosystems) thermocycler to measure expression of immunomodulatory and pro-inflammatory transcripts. All target gene expression was calculated relative to expression of housekeeping gene HPRT1, values below detection were not considered or plotted unless otherwise stated.
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Histology and Immunofluorescence microscopy.
For immunofluorescence microscopy, frozen sections of healthy entheseal soft tissue (EST) were incubated with fluorescently labelled antibodies against CD3 and RORγt (Supplementary Table 1) and counterstained with 4′,6-Diamidine-2′-phenylindole dihydrochloride (DAPI).
Tissue samples from Achilles' tendon, ACL ( Figure 1B ) and spinous process were prepared for histology using standard protocols and stained using mouse anti-human RORγt (Supplementary Table 1 ), EnVision+ horseradish staining system (Dako, Ely, UK) and counterstained with Harris haematoxylin.
Statistics
The Independent samples Kruskal-Wallis Test was used to detect differences between peripheral blood, EST and PEB samples with regards to the proportions of T-cells and cells classified as "others" in Figure 1C as well as CD4 neg CD8 neg T-cells and γδT-cells in Figure 1D . The Wilcoxon Signed Rank Test was used to detect changes in gene expression in entheseal digests with or without cytokine stimulation. The Mann-Whitney U test was used to detect difference between groups in all other data sets. Significance was set at >95%, SPSS version 21 (IBM) was used to calculate all statistics, GraphPad Prism 6 (GraphPad Software) was used to generate all graphs. Bar charts show mean and standard error, box plots show median (line), interquartile range (box) and extreme values (whiskers).
RESULTS
Immunological profiling of entheseal tissue
Initial assessment of the total entheseal lymphocyte content revealed significant differences in the proportions of T-cells between aged-matched peripheral mononuclear cells (PBMCs) and EST and PEB digests (p=0.018). There was also a significant difference in the percentage of cells not defined as T-cells, B-cells or NK-cells within these categories (p=0.016, Figure 1C ). Examination of T-cell subsets also showed an increase in the proportion of T-cells expressing neither the CD4 or CD8 antigen in entheseal digests compared to peripheral blood (p=0.021). Additionally, γδT-cells were also significantly increased in comparison to peripheral blood (p=0.027, Figure 1D ). Figure 2) , necessitating a cytometric approach to ILC3 detection. Digested entheseal tissue showed the consistent presence of ILCs as identified by cell surface phenotype ( Figure 1E ) (5).
ILC3s defined as Lin
In order to ascertain if ILCs detected in entheseal tissues were a resident population, as distinct from passenger cells merely trapped in the vasculature, the frequency of all ILCs in peripheral blood was compared to EST and PEB digests. EST had a substantially greater proportion of ILCs (p=0.008) compared to unmatched peripheral blood median 0.08% (0.03-0.20%), EST: 0.54% (0.06-2.06%), PEB: 0.24% (0.03-0.49%, Figure 1F ). The proportion of total ILCs identified as ILC3 and expressing the NKp44 cell surface antigen was also examined. In peripheral blood, the percentage of lymphocytes identified as ILC3s and expressing the NKp44 marker was 0.21% (0-1.13%) EST digests had a significantly greater proportion of these cells, median 5.3% (0.8-50.9%, p=0.001). These were also elevated in PEB digests, median 3.03% (0-13.84%, p=0.043) compared to peripheral blood (Figure1G). Taken together these data provide strong evidence that the ILC3 populations in EST and PEB tissue are entheseal resident and unlikely to originate from peri-entheseal blood vessels. In EST ILC3s constituted 0.25% (0.02-0.92%) of the total lymphocyte population. NKp44 -ILC3s constituted 0.16% (0.01-0.17%) and those expressing the NKp44 marker constituted 0.09% (4.25x10 -3 -0.23%).
Cells phenotypically identified as ILC1s constituted 0.20% (0-0.49), ILC2s 0.23% (0-1.17%) of the total lymphocytic fraction (Supplementary Table 2 ). The proportion of ILC subsets observed in PEB was broadly similar to EST; PEB did contain fewer ILC2s on average although this was not statistically significant.
Confirmation of ILC3 phenotype and comparison to synovial SpA origin ILC3s
Comparison of gene expression from ILC3s sorted from EST showed a highly significant increase in the expression of RORC (RORγt) transcript compared to unsorted entheseal derived mononuclear cells (p=0.009, Figure 2A ) confirming ILC3 phenotype (5). Similar results were obtained from ILC3s isolated from PEB (p=0.032, Figure 2B ). Since the frequency of ILC3s is known to be increased in the synovial fluid of patients suffering from SpA (7), comparison of immunomodulatory transcripts from ILC3s isolated from enthesis and SpA synovial fluid was made to further confirm ILC3 phenotype. Sorted ILC3 transcript analysis showed high expression of TGFβ and TNFα, both mediators with opposing immunomodulatory and inflammatory roles in the context of SpA respectively (12) . STAT3 was expressed in all tissues indicating potential for cytokine signal transduction but significantly higher level in PEB ILC3s compared to both EST and SpA synovial fluid ILC3s (p=0.048, Figure 2C ). Expression of IL-10 in ILC3s from three of five EST was noted and two of five PEB and SpA tissues, The EST ILC3s had no detectable IL-17A or IL-22; however, IL-17A message was detected in ILCs in two of five samples from normal PEB and in one of four samples from SpA synovial fluid. IL-22 message was detected in one sample from both PEB and SpA synovial fluid (data not shown). In general, transcript expression between ILC3 isolated from enthesis tissues and SpA fluid was similar, strengthening the proposition that these cells share common functionality.
Cytokine Stimulation of Enthesis
Examination of IL-23R expression from ILC3 isolated from either EST or PEB showed a significantly increased level of IL-23R transcript compared to unsorted mononuclear cells (p=0.033, Figure 2D ) both confirming immunophenotype data and the capacity for IL-23 responsiveness in these cells. Transcriptional analysis of IL-1β/IL-23 cytokine stimulated entheseal digests showed a significant increase (p=0.046) in expression of IL-17A ( Figure 2E ). Expression of IL-17F and IL-22 also showed a clear upward trend following stimulation although this fell short of significance ( Figures 2F and 2G ). These data provide functional support for human entheseal resident cells capable of IL-17A production in response to cytokine stimulation.
Evidence for ILC3s at sites of Enthesis Injury
Tissue from peri-entheseal regions of ruptured tendons showed inflammatory infiltrates expressing the RORγt protein this was observed in 2 of 3 donors ( Figure 3A) . Likewise, peri-entheseal tissue from intact ACL from osteoarthritic donors showed cells expressing the RORγt protein in entheseal soft tissue in 5 of 7 donors ( Figure 3B ) and in the peri-entheseal bone 7 of 7 donors ( Figure 3C ). Positive staining for RORγt was also observed in areas of active bone re-modelling in OA in 5 of 7 donors ( Figure 3D ). For comparison, healthy spinal tissue was also examined. Positive staining was absent in 6 of 7 of EST tissues ( Figure 3E ) as well as in control Achilles tendon (data not shown). Expression RORγt was observed in control PEB, harvested from spinous process ( Figure 3E ), and consistently present in cancellous bone harvested from iliac crest (data not shown).
DISCUSSION
Recently there has been a convergence of genetic, molecular and therapeutic data pointing towards a role for the IL-23/17 axis in the pathogenesis of the SpA group of related diseases including psoriasis and inflammatory bowel disease. With the expanding literature showing that group 3 ILCs play an important role in skin and gut homeostasis, we investigated whether ILC3s were present at the human enthesis a key target tissue in early SpA. The proportion of ILC3s expressing the NKp44 marker in entheseal soft tissue and peri-entheseal bone confirms that these cells are resident populations of ILCs and could not entirely be made-up cells released from peripheral blood vessels.
To confirm our phenotypic evaluation, RORγt transcript was measured in sorted ILC3s and found elevated RORγt transcript levels, an important ILC3 lineage transcription factor (4). The detection of IL-23R transcripts in ILC3 isolates gives additional confirmation of ILC3 phenotypes. Abundant TGFβ was found in normal enthesis ILC3s, possibly indicating an immunoregulatory phenotype in the absence of inflammatory signalling. However, TGFβ was also elevated in ILCs from SpA synovial fluid, a known inflammatory environment (7). Overall, ILC3s isolated from entheseal tissues and SpA synovial fluid were very similar in their expression of cytokine transcripts perhaps indicating comparable activation states. It should be noted that in this study transcriptional analysis was limited due to the low cellular yield from sorted populations. Indeed, in many cases conventional PCR was unable to resolve the expression levels of some genes of interest. Ultra-low cell number or single cell compatible techniques such as RNAseq may provide a more appropriate means of characterising entheseal populations in future.
Normal whole entheseal digests were stimulated with IL-1β and IL-23 and showed a clear increase in IL-17 and, to a lesser extent, IL-22 transcripts. Although this work does not address the cellular origin of these signals it nevertheless confirms that this relatively acellular tissue is capable of responding as a whole to stimulation by increasing IL-17 and IL-22 transcript production. RORγt transcription factor expression was found in inflammatory infiltrate of ruptured Achilles tendon tissue and in perientheseal bone in OA derived enthesis. Although it is likely that cells other than ILC3s, including Th17 cells, contribute a large portion of this signal this nevertheless highlights the involvement of the IL-23/IL-17 axis in responding to injury at the enthesis.
The elevated proportion of NKp44 + ILC3s is interesting from a functional perspective since it has been shown that NKp44 positive but not negative ILC3s are capable of producing IL-22 (5) . Given that IL-22 signalling has been implicated in promoting osteogenesis (13) , the presence of an elevated proportion of NKp44 + ILC3s may suggest a potential mechanism for spondyloarthropathy pathogenesis in respect to new bone formation.
The present studies in man was motivated by the emerging literature on ILCs and from the IL-23 dependent model of SpA reported by Sherlock et al (1) . Recent murine model studies have shown that this IL-23 SpA model is association with an accumulation of γδT-cells in entheseal regions (14) . These T-cells do not typically express CD4 or CD8 and share many similarities to ILC3s, particularly in their response to cytokine stimulation. Although some caution should be given to direct comparison between animal models and human disease, we noted that T-cells that lacked expression of CD4 and CD8 were elevated in entheseal digests. Further examination of T-cell subsets indicated that a high proportion of these cells were likely γδT-cells, further characterisation of this T-cell subset in human enthesis is important especially in light of the animal model data suggesting a role for γδT-cells in SpA pathogenesis (1, 14) .
In conclusion, this proof of concept work demonstrated that enthesis related soft tissue and perientheseal bone harbours a population of resident ILC3s. The frequency of such cells as a proportion of CD45+ lymphocytes is marginally lower (0.25% in EST, 0.07% in PEB) than that reported in gut (~0.90%) (15) and skin (0.35%) (9) . This lower frequency may be due to enthesis non-exposure to external environments compared to the skin and gut. Further work is needed to define the exact micro-anatomical topography of these rare cells and to look at other entheses around the body, as well as to undertake studies in disease. The ability to robustly define and purify these rare cells and define other immune cells at the enthesopathies opens up new avenues to explore immunity in early SpA. 
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